No increased risk of developing Alzheimer disease in patients with glaucoma

Journal of Glaucoma

Volumn 16, Issue 1, 2007, Pages 47-51

  Kessing, Lars V ^a,b   Lopez, Ana G ^b   Andersen, Per K ^b   Kessing, Sven V ^a  

^a International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Alzheimer disease; Cataract; Dementia; Glaucoma

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CATARACT; DENMARK; DISEASE ASSOCIATION; FEMALE; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; OPEN ANGLE GLAUCOMA; OUTPATIENT; POPULATION; PRIORITY JOURNAL; RISK ASSESSMENT;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CATARACT; DENMARK; FEMALE; GLAUCOMA, ANGLE-CLOSURE; GLAUCOMA, OPEN-ANGLE; HEALTH SURVEYS; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; REGISTRIES; RISK FACTORS;

EID: 33846278737     PISSN: 10570829     EISSN: None     Source Type: Journal    
DOI: 10.1097/IJG.0b013e31802b3527     Document Type: Article

References (30)

1. Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol. 1996;80:389-393.
2. McKinnon SJ. Glaucoma: ocular Alzheimer's disease? Front Biosci. 2003;8:s1140-s1156.
3. Vickers JC. The cellular mechanism underlying neuronal degeneration in glaucoma: parallels with Alzheimer's disease. Aust N Z J Ophthalmol. 1997;25:105-109.
4. Farkas RH, Grosskreutz CL. Apoptosis, neuroprotection, and retinal ganglion cell death: an overview. Int Ophthalmol Clin. 2001;41:111-130.
5. Choi J, Miller AM, Nolan MJ et al. Soluble CD44 is cytotoxic to trabecular meshwork and retinal ganglion cells in vitro. Invest Ophthalmol Vis Sci. 2005;46:214-222.
6. Bayer AU, Keller ON, Ferrari F, et al. Association of glaucoma with neurodegenerative diseases with apoptotic cell death: Alzheimer's disease and Parkinson's disease. Am J Ophthalmol. 2002;133:135-137.
7. Bayer AU, Ferrari F. Severe progression of glaucomatous optic neuropathy in patients with Alzheimer's disease. Eye. 2002;16:209-212.
8. Schwartz M. Lessons for glaucoma from other neurodegenerative diseases: can one treatment suit them all? J Glaucoma. 2005;14:321-323.
9. Andersen TF, Madsen M, Jorgensen J, et al. The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull. 1999;46:263-268.
10. Munk-Jorgensen P, Mortensen PB. The Danish Psychiatric Central Register. Dan Med Bull. 1997;44:82-84.
11. World Health Organisation. Glossary of Mental Disorders and Guide to Their Classification for Use in Conjunction With the International Classification of Diseases, 8th Revision. Geneva: World Health Organisation; 1974.
12. World Health Organisation. Klassifikation af Sygdomme. Systematisk Del. International Statistical Classification of Diseases and Health Related Problems, 10th Revision (Danish Edition). Copenhagen: Munksgaard; 1993.
13. Juel K, Helweg-Larsen K. The Danish registers of causes of death. Dan Med Bull. 1999;46:354-357.
14. Clayton D, Hills M. Statistical Models in Epidemiology. Oxford: Oxford University Press; 1993.
15. Berkson J. Limitations of the application of fourfold table analysis to hospital data. Biometric Bull. 1946;2:126-135.
16. Klegeris A, McGeer PL. Non-steroidal anti-inflammatory drugs (NSAIDs) and other anti-inflammatory agents in the treatment of neurodegenerative disease. Curr Alzheimer Res. 2005;2:355-365.
17. de Craen AJ, Gussekloo J, Vrijsen B, et al. Meta-analysis of nonsteroidal antiinflammatory drug use and risk of dementia. Am J Epidemiol. 2005;161:114-120.
18. Nilsson FM, Kessing LV, Sorensen TM, et al. Enduring increased risk of developing depression and mania in patients with dementia. J Neurol Neurosurg Psychiatry. 2002;73:40-44.
19. Kessing LV, Nilsson FM. Increased risk of developing dementia in patients with major affective disorders compared to patients with other medical illnesses. J Affect Disord. 2003;73:261-269.
20. Jurgensen HJ, Frolund C, Gustafsen J, et al. Registration of diagnoses in the Danish National Registry of Patients. Methods Inform Med. 1986;25:158-164.
21. Mosbech J, Jorgensen J, Madsen M, et al. The national patient registry. Evaluation of data quality. Ugeskr Laeger. 1995;157:3741-3745.
22. Kessing SV. Glaucoma, a multifactorial condition. Ugeskr Laeger. 1981;143:799-802.
23. Thygesen J, Kessing SV, Krogh E, et al, Danish Glaucoma Society. Primary open angle glaucoma and ocular hypertension. 1997. Danish Glaucoma Society (Dansk Glaukom Selskab). Available at: www.glaucoma.dk. Accessed November 6, 2006.
24. American Academy of Ophtalmology, Glaucoma Panel. Primary open-angle glaucoma. 2005:1-36. Available at: www.aao.org. Accessed November 6, 2006.
25. Turacli ME, Tekeli O, Bingøl A, et al. Scanning laser polarimetry of retinal nerve fiber layer in Alzheimers disease (Conference Proceeding). Poster 115. World Glaucoma Congress. Vienna; 2005.
26. Lee AG, Martin CO. Neuro-ophthalmic findings in the visual variant of Alzheimer's disease. Ophthalmology. 2004;111:376-380.
27. Sadun AA, Bassi CJ. Optic nerve damage in Alzheimer's disease. Ophthalmology. 1990;97:9-17.
28. Davies DC, McCoubrie P, McDonald B, et al. Myelinated axon number in the optic nerve is unaffected by Alzheimer's disease. Br J Ophthalmol. 1995;79:596-600.
29. Kergoat H, Kergoat MJ, Justino L, et al. An evaluation of the retinal nerve fiber layer thickness by scanning laser polarimetry in individuals with dementia of the Alzheimer type. Acta Ophthalmol Scand. 2001;79:187-191.
30. Parisi V. Correlation between morphological and functional retinal impairment in patients affected by ocular hypertension, glaucoma, demyelinating optic neuritis and Alzheimer's disease. Semin Ophthalmol. 2003;18:50-57.